BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 132 filers reported holding BRIDGEBIO PHARMA INC in Q3 2020. The put-call ratio across all filers is 0.69 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $910,029 | +46.3% | 34,510 | -4.5% | 0.00% | – |
| Q2 2023 | $621,866 | -0.3% | 36,155 | -3.9% | 0.00% | – |
| Q1 2023 | $623,740 | +34.7% | 37,620 | -38.0% | 0.00% | – |
| Q4 2022 | $463,000 | -24.0% | 60,717 | -0.9% | 0.00% | – |
| Q3 2022 | $609,000 | +250.0% | 61,247 | +219.1% | 0.00% | – |
| Q2 2022 | $174,000 | -74.2% | 19,195 | -52.5% | 0.00% | – |
| Q4 2021 | $674,000 | -65.6% | 40,372 | -3.4% | 0.00% | -100.0% |
| Q3 2021 | $1,960,000 | -16.5% | 41,812 | +8.5% | 0.00% | 0.0% |
| Q2 2021 | $2,348,000 | +8.3% | 38,519 | +9.4% | 0.00% | 0.0% |
| Q1 2021 | $2,169,000 | -28.4% | 35,211 | -17.3% | 0.00% | 0.0% |
| Q4 2020 | $3,030,000 | +82.6% | 42,602 | -3.7% | 0.00% | 0.0% |
| Q3 2020 | $1,659,000 | +8.7% | 44,239 | -5.5% | 0.00% | 0.0% |
| Q2 2020 | $1,526,000 | -10.0% | 46,802 | -20.0% | 0.00% | 0.0% |
| Q1 2020 | $1,696,000 | +66.9% | 58,492 | +101.9% | 0.00% | – |
| Q4 2019 | $1,016,000 | +71.9% | 28,973 | +5.2% | 0.00% | – |
| Q3 2019 | $591,000 | -12.7% | 27,544 | +9.7% | 0.00% | – |
| Q2 2019 | $677,000 | – | 25,115 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 6,068,125 | $100,609,513 | 48.41% |
| Kohlberg Kravis Roberts & Co. L.P. | 31,060,971 | $514,990,899 | 15.50% |
| M28 Capital Management LP | 304,700 | $5,051,926 | 5.71% |
| Cormorant Asset Management, LP | 4,557,414 | $75,562 | 4.98% |
| Octagon Capital Advisors LP | 1,338,160 | $22,186,693 | 3.19% |
| Ikarian Capital, LLC | 594,686 | $9,859,894 | 2.24% |
| Affinity Asset Advisors, LLC | 389,800 | $6,462,884 | 2.13% |
| VIKING GLOBAL INVESTORS LP | 26,620,991 | $441,376,031 | 2.07% |
| Ikarian Capital, LLC | 549,600 | $9,112,368 | 2.07% |
| Affinity Asset Advisors, LLC | 320,000 | $5,305,600 | 1.75% |